CDK2 degrader 6
Based on 1 Customer Validation
CDK2 degrader 6 is an orally active and potent CDK2 molecular glue degrader with a DC50 of 46.5 nM. CDK2 degrader 6 binds to cereblon and CDK2 to induce ubiquitination and subsequent proteasomal degradation of CDK2. CDK2 degrader 6 modulates cell cycle in breast cancer cells. CDK2 degrader 6 reduces proliferation of breast cancer cells. CDK2 degrader 6 exhibits in vivo antitumor activity in gastric cancer mouse models. CDK2 degrader 6 can be used for the research of breast cancer, gastric cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 純度: 99.81%
- CAS 番号: 3036606-92-2
- 分子式: C23H22F5N5O3
- 分子量:511.44
-
保管条件:
-20°C, stored under nitrogen, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
生物活性
|
CDK2 46.5 nM (DC50) |
CDK2 degrader 6 (compound 6) (24 h) potently induces degradation of CDK2 in CDK2 HiBiT-tagged HEK293 cells, with a 62.0% maximal reduction in CDK2 protein levels and a DC50 of 46.5 nM after 24 hours of treatment[1].
CDK2 degrader 6 (24 h) shows minimal activity in degrading GSPT1 in GSPT1 HiBiT-tagged HEK293 cells, with only a 9.9% maximal reduction in GSPT1 protein levels after 24 hours of treatment[1].
CDK2 degrader 6 (0.316-1000 nM; 7 days) potently inhibits proliferation of MDA-MB-157 breast cancer cells, with a 90% maximal reduction in cell proliferation and an EC50 of 10 nM after 7 days of treatment[1].
CDK2 degrader 6 (152 nM-1000 nM; 24 h) potently induces degradation of CDK2 protein in MDA-MB-157 breast cancer cells, with an 84% maximal reduction in CDK2 levels and a DC50 of 4 nM after 24 hours of treatment[1].
CDK2 degrader 6 (10-1000 nM; 24 h) disrupts the cell cycle of MDA-MB-157 breast cancer cells, causing dose-dependent G1 phase arrest and reduction in S phase cells after 24 hours of treatment at concentrations from 10 nM to 1000 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MDA-MB-157 breast cancer cells
-
Concentration:0.316 nM, 1 nM, 3.16 nM, 10 nM, 31.6 nM, 100 nM, 316 nM, 1000 nM
-
Incubation Time:7 days
-
Result:Reduced cell proliferation by 90% relative to DMSO controls, with an EC50 of 10 nM.
-
Cell Line:MDA-MB-157 breast cancer cells
-
Concentration:0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM
-
Incubation Time:24 h
-
Result:Induced a maximal 84% reduction in CDK2 protein levels, with a DC50 of 4 nM.
-
Cell Line:MDA-MB-157 breast cancer cells
-
Concentration:10 nM, 100 nM, 1000 nM
-
Incubation Time:24 h
-
Result:Caused a dose-dependent accumulation of cells in the G1 phase (56.3% in DMSO controls vs 65.4% at 1000 nM) and a reduction in cells in the S phase (35.8% in DMSO controls vs 3.1% at 1000 nM).
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Mice injected with MKN1[1]
-
Dosage:30 mg/kg; 100 mg/kg
-
Administration:p.o.; twice daily; 21 days
-
Result:Achieved 45% tumor growth inhibition (TGI) on day 21, with a statistically significant difference compared to vehicle.
Achieved 47% tumor growth inhibition (TGI) on day 21, with a statistically significant difference compared to vehicle.
化学情報
-
CAS 番号 3036606-92-2
-
性状 Solid
-
分子量 511.44
-
分子式 C23H22F5N5O3
-
Color Off-white to light yellow
-
SMILES
O=C(C(CC1)C2=C(F)C=C(N3C[C@H](NC4=NN=C(C56CC(C6)(C(F)(F)F)C5)O4)[C@H]3C)C=C2F)NC1=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
-20°C, stored under nitrogen, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)
溶剤 & 溶解度
DMSO : 15 mg/mL (29.33 mM; Need ultrasonic and warming; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
純度とドキュメンテーション
-
データシート (275 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
取扱説明書 (2659 KB)
参考文献
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9553 mL | 9.7763 mL | 19.5526 mL | 48.8816 mL |
| 5 mM | 0.3911 mL | 1.9553 mL | 3.9105 mL | 9.7763 mL | |
| 10 mM | 0.1955 mL | 0.9776 mL | 1.9553 mL | 4.8882 mL | |
| 15 mM | 0.1304 mL | 0.6518 mL | 1.3035 mL | 3.2588 mL | |
| 20 mM | 0.0978 mL | 0.4888 mL | 0.9776 mL | 2.4441 mL | |
| 25 mM | 0.0782 mL | 0.3911 mL | 0.7821 mL | 1.9553 mL |